EPINEPHRINE MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Epinephrine Market - Overview Global Epinephrine Market, by Product Type (Auto-injector, Prefilled Syringes, and Ampoules and Vials), by Application (Anaphylaxis, Cardiac Arrest, Superficial Bleeding, Respiratory Disorders, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 2,040 million in 2017, and is projected to exhibit a CAGR of 11.0% over the forecast period (2018 – 2026), as highlighted in a new report published by. Significant number of novel pipeline products to augment the market growth the manufacturers are focused on developing and commercializing innovative drugs and novel drug delivery systems of therapeutic molecules to improve patient quality of life and to cater the clinical shortcomings of the commercially available products. According to the Mayo Clinic, 2016, more than 200,000 cases of anaphylaxis occur annually in the U.S., indicating the higher number of potential patient pool in the region. Also, the World Allergy Organization, in 2015 estimated that up to two percent of the global population, accounting for 150 million people are expected to experience anaphylaxis during their lifetime. In July 2018, INSYS Therapeutics, Inc. demonstrated the results of early clinical trial for its investigational epinephrine nasal spray, as a potential needle-free, non-invasive, and easy-to-use alternative to intramuscular injection for the treatment of anaphylaxis. Browse Research Reports: https://www.coherentmarketinsights.com/marketinsight/epinephrine-market-2401 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Browse 36 Market Data Tables and 34 Figures spread through 175 Pages and in-depth TOC on “Epinephrine Market”- Global Forecast to 2026, by Product Type (Auto-injector, Prefilled Syringes, and Ampoules and Vials), by Application (Anaphylaxis, Cardiac Arrest, Superficial Bleeding, Respiratory Disorders and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) The market players are focused on strengthening strategic collaborations to provide products freely at retail outlets, considering shortages in supply of competitors' epinephrine autoinjectors. For instance, in September 2018, Walgreens and Kaleo entered into partnership under which AUVI-Q would be available at all pharmacies across the U.S. This step will aid in increasing accessibility of epinephrine auto-injector. Also, in July 2018, Adamis Pharmaceuticals announced that Sandoz, a Novartis division, bought the rights to market its epinephrine device, a pre-filled 0.3 mg-dose syringe called Symjepi in the U.S. market. In 2015, Impax Laboratories, Inc. acquired Tower Holdings, Inc. including subsidiaries Amedra Pharmaceuticals LLC. Amedra is manufacturer of the Adrenaclick (epinephrine injection) autoinjector.
The investigators also highlighted the benefits of effective needleless alternative delivery options showing rapid drug absorption. In August 2018, FDA granted Fast Track designation for the epinephrine nasal spray. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2401 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Key Takeaways of the Epinephrine Market: The global epinephrine market is expected to exhibit a CAGR of 11.0% over the forecast period, owing to the approval of cost-effective generic auto-injectors in the market, and strategic support of companies and government agencies for increasing generic epinephrine adoption.
Among product type, auto-injector segment held a dominant position in the epinephrine market in 2018, owing to the wide use of the product in auto-injectable form due to ease of administration and rapid onset of action. Among application, anaphylaxis segment held a dominant position in the epinephrine market in 2018, owing to high incidence rate of anaphylaxis due to consumption of food products such as peanut or tree nut in children and increasing supplemental new drug application in infants. Companies operating in the global epinephrine market include Mylan N.V., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Impax Laboratories, Inc., Kaleo, Inc., Adamis Pharmaceuticals Corporation, Bausch Health Companies, ALK- Abello A/S Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2401 © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry
Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
© Coherent market Insights. All Rights Reserved